Validation of drug prescription records for senior patients in Alberta's Tomorrow Project: Assessing agreement between two population-level administrative pharmaceutical databases in Alberta, Canada.
Alberta Blue Cross
Alberta's Tomorrow Project
Pharmaceutical Information Network
drug prescription records
pharmacoepidemiology
seniors
Journal
Pharmacoepidemiology and drug safety
ISSN: 1099-1557
Titre abrégé: Pharmacoepidemiol Drug Saf
Pays: England
ID NLM: 9208369
Informations de publication
Date de publication:
10 2019
10 2019
Historique:
received:
23
01
2019
revised:
23
05
2019
accepted:
17
06
2019
pubmed:
28
7
2019
medline:
1
7
2020
entrez:
27
7
2019
Statut:
ppublish
Résumé
To assess agreement between the Pharmaceutical Information Network (PIN), a newly implemented medication data repository in Alberta, Canada, and the Alberta Blue Cross (ABC) database, a long established database with medication records of all senior patients in Alberta. PIN data (2008-2015) were cross-validated with ABC medication records for senior participants (older than 65 years old) in Alberta's Tomorrow Project (ATP), a longitudinal cohort study in Alberta. The completeness and accuracy of PIN were respectively calculated as the percentage of ABC records coexisting (concordant) in PIN and the percentage of concordant records having mutually agreeable information on drug quantity. Generalized linear models were used to examine potential association of PIN completeness and accuracy with sociodemographic factors. A total of 1 218 191 drug prescription records from 13 143 ATP participants were captured by PIN and ABC in 2008-2015, among which 91.6% were from PIN, 82.5% from ABC, and 74.2% coexisted in PIN and ABC. The overall completeness of PIN in capturing ABC medication records was 89.9%, with small variations (less than ±5%) across types of drugs. The completeness of PIN was improved on average by 1.3% annually over time (P < .001). PIN had 100% accuracy as defined by drug quantity data agreeable with ABC records. No significant associations were observed with age, sex, ethnicity, rural/urban areas, and socioeconomic status of the participants. Cross-validated with the ABC dataset, our study showed that irrespective of drug type, PIN has a fairly good completeness (approximately 90%) and accuracy (100%) in capturing the ABC claimed medications for senior patients in Alberta.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Validation Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1417-1421Informations de copyright
© 2019 John Wiley & Sons, Ltd.
Références
Alberta Health. Pharmaceutical Information Network (PIN). 2017; http://www.albertanetcare.ca/learningcentre/Pharmaceutical-Information-Network.htm.
Morgan SG, Law M, Daw JR, Abraham L, Martin D. Estimated cost of universal public coverage of prescription drugs in Canada. CMAJ: Canadian Medical Association journal = journal de l'Association medicale canadienne. 2015;187(7):491-497.
Health Canada. Provincial and Territorial Public Drug Benefit Programs. 2017; https://www.canada.ca/en/health-canada/services/health-care-system/pharmaceuticals/access-insurance-coverage-prescription-medicines/provincial-territorial-public-drug-benefit-programs.html. Accessed May 1st, 2017, 2017.
Sproule B. Prescription Monitoring Programs in Canada: Best Practice and Program Review. 2015; http://www.ccsa.ca/Resource%20Library/CCSA-Prescription-Monitoring-Programs-in-Canada-Report-2015-en.pdf, 2018.
Alberta Blue Cross. History of Alberta Blue Cross. 2017; https://www.ab.bluecross.ca/aboutus/history.php.
Bryant H, Robson PJ, Ullman R, Friedenreich C, Dawe U. Population-based cohort development in Alberta, Canada: a feasibility study. Chronic Dis Can. 2006;27(2):51-59.
Ye M, Robson PJ, Eurich DT, Vena JE, Xu JY, Johnson JA. Cohort profile: Alberta's Tomorrow Project. Int J Epidemiol. 2016;46:1097-1098l.
Hersh WR. Adding value to the electronic health record through secondary use of data for quality assurance, research, and surveillance. Am J Manag Care. 2007;13(6 Part 1):277-278.
Alberta Health. An Overview of Alberta's EHR. 2015; http://www.albertanetcare.ca/Publications.htm.
Rowan CG, Flory J, Gerhard T, et al. Agreement and validity of electronic health record prescribing data relative to pharmacy claims data: a validation study from a US electronic health record database. Pharmacoepidemiol Drug Saf. 2017;26(8):963-972.
Drieling RL, LaCroix AZ, Beresford SA, Boudreau DM, Kooperberg C, Heckbert SR. Validity of self-reported medication use compared with pharmacy records in a cohort of older women: findings from the women's health initiative. Am J Epidemiol. 2016;184(3):233-238.
Richardson K, Kenny RA, Peklar J, Bennett K. Agreement between patient interview data on prescription medication use and pharmacy records in those aged older than 50 years varied by therapeutic group and reporting of indicated health conditions. J Clin Epidemiol. 2013;66(11):1308-1316.
Noize P, Bazin F, Dufouil C, et al. Comparison of health insurance claims and patient interviews in assessing drug use: data from the Three-City (3C) Study. Pharmacoepidemiol Drug Saf. 2009;18(4):310-319.
Curtis JR, Westfall AO, Allison J, Freeman A, Kovac SH, Saag KG. Agreement and validity of pharmacy data versus self-report for use of osteoporosis medications among chronic glucocorticoid users. Pharmacoepidemiol Drug Saf. 2006;15(10):710-718.